Japan's PeptiDream inks $40 M deal with Genentech for novel peptide-radioisotope drug conjugates
Drug Discovery | News | 0 Comment | 20 Sep, 2023
PeptiDream Inc., a Japan-based biopharmaceutical company, has announced a new multi-target collaboration and license agr...Read more
Korea-US partnership to revolutionise AI-based early drug discovery
Drug Discovery | News | 0 Comment | 16 Aug, 2023
South Korea-based startup Standigm, a company using artificial intelligence (AI) technology for drug discovery and devel...Read more
Japan-based Chugai Pharma and Omron focus on automation for drug discovery research
Drug Discovery | News | 0 Comment | 17 Jul, 2023
Japanese firms Chugai Pharmaceutical Co., and Omron Corporation are working together on the automation of research proce...Read more
AI & Biotech- Transforming each other!
Drug Discovery | Analysis | 0 Comment | 05 Jul, 2023
Rapid developments are taking place across the fields of artificial intelligence (AI) and biotechnology, and application...Read more
University of Sydney inks MoU with Pharos Therapeutics for AI-based drug discovery
Drug Discovery | News | 0 Comment | 31 May, 2023
The University of Sydney, Australia has signed a Memorandum of Understanding (MoU) with Pharos Therapeutics, the Austral...Read more
Korea-US partnership to co-develop therapy for Parkinson's Disease
Drug Discovery | News | 0 Comment | 26 May, 2023
South Korean firms HanAll Biopharma and Daewoong Pharmaceutical have entered into a co-development agreement with N...Read more
Japan govt injects $200M to support third phase operations of GHIT Fund
Drug Discovery | News | 0 Comment | 26 May, 2023
Prime Minister Fumio Kishida has recently announced the Government of Japan's pledge to contribute&n...Read more
Korean firm Avixgen to expedite drug pipeline development and pursue IPO in 2025
Drug Discovery | News | 0 Comment | 25 May, 2023
South Korea-based Avixgen is currently having a strong pipeline in ophthalmic diseases such as age related macular degen...Read more
Biodrug Design Accelerator platform launches in Japan to accelerate peptide drug discovery research
Drug Discovery | News | 0 Comment | 18 May, 2023
Japanese firm Fujitsu has announced the commercial debut of its "Biodrug Design Accelerator," a platform to manage resea...Read more
Japan's Otsuka Pharma gets US FDA nod for drug to treat agitation during Alzheimer's
Drug Discovery | News | 0 Comment | 12 May, 2023
The US Food and Drug Administration (FDA) has announced the supplemental approval of Rexulti (brexpiprazole) o...Read more
Japan's Eisai inks $2 B oncology deal with China-based startup Bliss Biopharma
Drug Discovery | News | 0 Comment | 08 May, 2023
Japanese pharmaceutical firm Eisai Co. has entered into a joint development agreement with China-based startup Bliss Bio...Read more
Korea's Daewoong Pharma inks $477 M deal with US partner for autoimmune disease treatment
Drug Discovery | News | 0 Comment | 28 Apr, 2023
South Korea-based Daewoong Pharmaceutical has signed a Global License Agreement for its autoimmune disease drug can...Read more
New drug discovery research collaboration between Korea & UK
Drug Discovery | News | 0 Comment | 19 Apr, 2023
South Korean firm Daewoong Pharmaceutical has entered a research collaboration with UK-based Sygnature Discovery to expa...Read more
Eisai invests ¥ 8.5 B to revamp Tsukuba Research Laboratories in Japan
Drug Discovery | News | 0 Comment | 08 Apr, 2023
Japanese pharmaceutical firm Eisai Co. has announced the completion of a major renovation of its Tsukuba Research Labora...Read more
Japanese firm Takeda Pharma inks $415 M deal for celiac disease research
Drug Discovery | News | 0 Comment | 03 Apr, 2023
French firm Innate Pharma has entered into an exclusive license agreement with Japanese pharmaceutical company Takeda un...Read more
Japan's NEC establishes European subsidiaries for strengthening global AI drug development biz
Drug Discovery | News | 0 Comment | 31 Mar, 2023
Japan-based NEC Corporation announced in 2019 that it would expand the application of its cutting-edge artificial inte...Read more
GHIT fund in Japan invests $2.9 M for treatment of neglected tropical diseases
Drug Discovery | News | 0 Comment | 30 Mar, 2023
The Global Health Innovative Technology (GHIT) Fund, in Japan, has announced an investment totaling approximately 400 mi...Read more
Collaboration in Korea to develop innovative therapeutic antibodies
Drug Discovery | News | 0 Comment | 17 Mar, 2023
Genuv Inc., a clinical-stage biotechnology startup focused on drug discovery, and South Korea headquartred Celltrion, a ...Read more